NCT02641236View on ClinicalTrials.gov

Gut Decontamination In Pediatric Allogeneic Hematopoietic

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 15, 2021

Study Completion Date

October 28, 2021

Conditions
Hematopoietic Stem Cell Transplantation (HSCT)Acute GVH Disease
Interventions
DRUG

Vancomycin-polymyxin B

Trial Locations (2)

02115

Boston Children's Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02641236 - Gut Decontamination In Pediatric Allogeneic Hematopoietic | Biotech Hunter | Biotech Hunter